Citadel Advisors »

Enliven Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $54M 2.3M 23.37
2024-03-31 $41M 2.4M 17.59
2023-12-31 $33M 2.4M 13.84
2023-09-30 $32M 2.4M 13.66
2023-06-30 $47M 2.3M 20.41
2023-03-31 $50M 2.3M 21.90